K. A. Abdul Nazeer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
K. A. Abdul Nazeer has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Meeta Pradhan
IU School of Informatics and Computing, Indiana University Purdue University Indianapolis, Indianapolis, IN, USA
5 shared publications- Nabizath Saleena
Department of Computer Science and Engineering, National Institute of Technology Calicut, Calicut 673601, Kerala, India
4 shared publications Mathew J Palakal
School of Informatics, Indiana University Purdue University Indianapolis, Indiana, USA 46202
3 shared publications- R. Visakh
Department of Computer Science and Engineering, NIT Calicut, Kerala, India
3 shared publications - E. K. Jasila
Department of Computer Science and Engineering, National Institute of Technology Calicut, Kozhikode, Kerala, India
2 shared publications - Gopakumar Gopalakrishnan
Department of Computer Science and Engineering, National Institute of Technology Calicut, Kerala, India
2 shared publications
Latest Publications
- 1 September 2025
- Published by World Scientific Pub Co Pte Ltd in International Journal on Artificial Intelligence Tools
- Vol. 34 (06)
Towards Drug Repurposing for Leukemia: An Ensemble Graph Neural Network Model for Drug Response Prediction
Drug response prediction is an essential part of precision medicine, which assesses the efficacy of drugs in specific cancer cell lines. Recently, numerous deep learning models have been developed for drug response prediction. The ability to effectively represent complicated interactions within a network makes Graph Neural Network (GNN) models a prominent area of exploration. To exploit the diverse capabilities of different GNN models, the proposed model uses an ensemble approach that combines results from Graph Convolutional Network (GCN), Graph SAmple and aggreGatE Network (GraphSAGE) and Graph Attention Network (GAT)-based models for drug response prediction. The proposed ensemble GNN model is used to predict the efficacy of drugs in treating leukemia. The model outperformed individual models when evaluated with the GDSC1000 dataset, with lower root mean squared error, higher Pearson’s correlation coefficient, higher coefficient of determination and higher Spearman’s correlation coefficient. Furthermore, most of the drugs identified by the model as potential candidates for the treatment of leukemia are currently in clinical trials or have supporting evidence in the PubMed literature database.
- 1 September 2025
- Published by World Scientific Pub Co Pte Ltd in International Journal on Artificial Intelligence Tools
- Vol. 34 (06)
Towards Drug Repurposing for Leukemia: An Ensemble Graph Neural Network Model for Drug Response Prediction
Drug response prediction is an essential part of precision medicine, which assesses the efficacy of drugs in specific cancer cell lines. Recently, numerous deep learning models have been developed for drug response prediction. The ability to effectively represent complicated interactions within a network makes Graph Neural Network (GNN) models a prominent area of exploration. To exploit the diverse capabilities of different GNN models, the proposed model uses an ensemble approach that combines results from Graph Convolutional Network (GCN), Graph SAmple and aggreGatE Network (GraphSAGE) and Graph Attention Network (GAT)-based models for drug response prediction. The proposed ensemble GNN model is used to predict the efficacy of drugs in treating leukemia. The model outperformed individual models when evaluated with the GDSC1000 dataset, with lower root mean squared error, higher Pearson’s correlation coefficient, higher coefficient of determination and higher Spearman’s correlation coefficient. Furthermore, most of the drugs identified by the model as potential candidates for the treatment of leukemia are currently in clinical trials or have supporting evidence in the PubMed literature database.
- 1 February 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Bioinformatics and Computational Biology
- Vol. 23 (01) , 2550001
Drug repurposing for non-small cell lung cancer by predicting drug response using pathway-level graph convolutional network
Drug repurposing is the process of identifying new clinical indications for an existing drug. Some of the recent studies utilized drug response prediction models to identify drugs that can be repurposed. By representing cell-line features as a pathway–pathway interaction network, we can better understand the connections between cellular processes and drug response mechanisms. Existing deep learning models for drug response prediction do not integrate known biological pathway–pathway interactions into the model. This paper presents a drug response prediction model that applies a graph convolution operation on a pathway–pathway interaction network to represent features of cancer cell-lines effectively. The model is used to identify potential drug repurposing candidates for Non-Small Cell Lung Cancer (NSCLC). Experiment results show that the inclusion of graph convolutional model applied on a pathway–pathway interaction network makes the proposed model more effective in predicting drug response than the state-of-the-art methods. Specifically, the model has shown better performance in terms of Root Mean Squared Error, Coefficient of Determination, and Pearson’s Correlation Coefficient when applied to the GDSC1000 dataset. Also, most of the drugs that the model predicted as top candidates for NSCLC treatment are either undergoing clinical studies or have some evidence in the PubMed literature database.
- 1 February 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Bioinformatics and Computational Biology
- Vol. 23 (01) , 2550001
Drug repurposing for non-small cell lung cancer by predicting drug response using pathway-level graph convolutional network
Drug repurposing is the process of identifying new clinical indications for an existing drug. Some of the recent studies utilized drug response prediction models to identify drugs that can be repurposed. By representing cell-line features as a pathway–pathway interaction network, we can better understand the connections between cellular processes and drug response mechanisms. Existing deep learning models for drug response prediction do not integrate known biological pathway–pathway interactions into the model. This paper presents a drug response prediction model that applies a graph convolution operation on a pathway–pathway interaction network to represent features of cancer cell-lines effectively. The model is used to identify potential drug repurposing candidates for Non-Small Cell Lung Cancer (NSCLC). Experiment results show that the inclusion of graph convolutional model applied on a pathway–pathway interaction network makes the proposed model more effective in predicting drug response than the state-of-the-art methods. Specifically, the model has shown better performance in terms of Root Mean Squared Error, Coefficient of Determination, and Pearson’s Correlation Coefficient when applied to the GDSC1000 dataset. Also, most of the drugs that the model predicted as top candidates for NSCLC treatment are either undergoing clinical studies or have some evidence in the PubMed literature database.
- Open Access
- 14 November 2024
- Published by RGN Publications in Communications in Mathematics and Applications
- Vol. 15 (2) , 929-945
The ScispaCy Clinical Term Extraction and Snomed CT Synonymy Elimination From Clinical Data For Clustering: A Novel Study
A clinical document is a written or electronic record that encompasses details regarding a patient’s medical procedure, clinical trial, or test outcomes. Standard information mining approaches have challenges in clustering clinical documents due to their unstructured nature. This work introduced a new approach for grouping clinical documents to address problems related to synonymy, abbreviation extension, and extraction of key features. The clinical document collection for coronary artery disease consists of 1304 records obtained from 296 patients. These records have been chosen for preprocessing with the aim of removing any irregularities. The scispaCy model extracts relevant information after a simple letter-matching algorithm identifies and extends abbreviations. Furthermore, the features are examined using SNOMED CT ontology to eradicate medical terms that have similar meanings. The TF-IDF method is employed to convert the recovered features into vectors. The BERT model’s word embeddings were employed in this study to represent features. Nevertheless, the TF-IDF model surpasses the BERT model in performance. The clustering process utilises an enhanced k-means algorithm that incorporates the Red-Black Tree data structure. The recommended strategy was evaluated with several existing clustering algorithms in this study. It has been found that the proposed method produces clusters with higher scores for Normalised Mutual Information (NMI) and accuracy. Based on the results of this investigation, the model has the ability to detect individuals with similar diseases and provide assistance to healthcare professionals.
- 14 November 2024
- Published by RGN Publications in Communications in Mathematics and Applications
- Vol. 15 (2) , 929-945
Open AccessThe ScispaCy Clinical Term Extraction and Snomed CT Synonymy Elimination From Clinical Data For Clustering: A Novel Study
A clinical document is a written or electronic record that encompasses details regarding a patient’s medical procedure, clinical trial, or test outcomes. Standard information mining approaches have challenges in clustering clinical documents due to their unstructured nature. This work introduced a new approach for grouping clinical documents to address problems related to synonymy, abbreviation extension, and extraction of key features. The clinical document collection for coronary artery disease consists of 1304 records obtained from 296 patients. These records have been chosen for preprocessing with the aim of removing any irregularities. The scispaCy model extracts relevant information after a simple letter-matching algorithm identifies and extends abbreviations. Furthermore, the features are examined using SNOMED CT ontology to eradicate medical terms that have similar meanings. The TF-IDF method is employed to convert the recovered features into vectors. The BERT model’s word embeddings were employed in this study to represent features. Nevertheless, the TF-IDF model surpasses the BERT model in performance. The clustering process utilises an enhanced k-means algorithm that incorporates the Red-Black Tree data structure. The recommended strategy was evaluated with several existing clustering algorithms in this study. It has been found that the proposed method produces clusters with higher scores for Normalised Mutual Information (NMI) and accuracy. Based on the results of this investigation, the model has the ability to detect individuals with similar diseases and provide assistance to healthcare professionals.
- 1 June 2024
- Published by World Scientific Pub Co Pte Ltd in Journal of Bioinformatics and Computational Biology
- Vol. 22 (03) , 2450013
Integration of autoencoder and graph convolutional network for predicting breast cancer drug response
Background and objectives: Breast cancer is the most prevalent type of cancer among women. The effectiveness of anticancer pharmacological therapy may get adversely affected by tumor heterogeneity that includes genetic and transcriptomic features. This leads to clinical variability in patient response to therapeutic drugs. Anticancer drug design and cancer understanding require precise identification of cancer drug responses. The performance of drug response prediction models can be improved by integrating multi-omics data and drug structure data. Methods: In this paper, we propose an Autoencoder (AE) and Graph Convolutional Network (AGCN) for drug response prediction, which integrates multi-omics data and drug structure data. Specifically, we first converted the high dimensional representation of each omic data to a lower dimensional representation using an AE for each omic data set. Subsequently, these individual features are combined with drug structure data obtained using a Graph Convolutional Network and given to a Convolutional Neural Network to calculate IC[ ] values for every combination of cell lines and drugs. Then a threshold IC[ ] value is obtained for each drug by performing K-means clustering of their known IC[ ] values. Finally, with the help of this threshold value, cell lines are classified as either sensitive or resistant to each drug. Results: Experimental results indicate that AGCN has an accuracy of 0.82 and performs better than many existing methods. In addition to that, we have done external validation of AGCN using data taken from The Cancer Genome Atlas (TCGA) clinical database, and we got an accuracy of 0.91. Conclusion: According to the results obtained, concatenating multi-omics data with drug structure data using AGCN for drug response prediction tasks greatly improves the accuracy of the prediction task.
- 1 June 2024
- Published by World Scientific Pub Co Pte Ltd in Journal of Bioinformatics and Computational Biology
- Vol. 22 (03) , 2450013
Integration of autoencoder and graph convolutional network for predicting breast cancer drug response
Background and objectives: Breast cancer is the most prevalent type of cancer among women. The effectiveness of anticancer pharmacological therapy may get adversely affected by tumor heterogeneity that includes genetic and transcriptomic features. This leads to clinical variability in patient response to therapeutic drugs. Anticancer drug design and cancer understanding require precise identification of cancer drug responses. The performance of drug response prediction models can be improved by integrating multi-omics data and drug structure data. Methods: In this paper, we propose an Autoencoder (AE) and Graph Convolutional Network (AGCN) for drug response prediction, which integrates multi-omics data and drug structure data. Specifically, we first converted the high dimensional representation of each omic data to a lower dimensional representation using an AE for each omic data set. Subsequently, these individual features are combined with drug structure data obtained using a Graph Convolutional Network and given to a Convolutional Neural Network to calculate IC[ ] values for every combination of cell lines and drugs. Then a threshold IC[ ] value is obtained for each drug by performing K-means clustering of their known IC[ ] values. Finally, with the help of this threshold value, cell lines are classified as either sensitive or resistant to each drug. Results: Experimental results indicate that AGCN has an accuracy of 0.82 and performs better than many existing methods. In addition to that, we have done external validation of AGCN using data taken from The Cancer Genome Atlas (TCGA) clinical database, and we got an accuracy of 0.91. Conclusion: According to the results obtained, concatenating multi-omics data with drug structure data using AGCN for drug response prediction tasks greatly improves the accuracy of the prediction task.
- 11 February 2023
- Published by Taylor & Francis in Cybernetics and Systems
- Vol. 56 (5) , 526-543
An Efficient Document Clustering Approach for Devising Semantic Clusters
The rise of superfluous information day by day has made the clustering of information into meaningful sets challenging. We propose an efficient approach for obtaining semantic clusters from a huge volume of documents. The preprocessing based on the lexical ontological information from WordNet helps in reducing the feature space and eliminating synonymy problems among the features. A considerable decrease in computational time is achieved by means of an enhanced k-means clustering algorithm. This algorithm computes the starting centroids using a sorting technique based on Red-Black Tree, thus ensuring efficiency and meaningful clusters. Memoization techniques are utilized in the subsequent stages, to avoid redundant computations. Results indicate that our method produces more meaningful clusters than those employing word embedding models like Word2Vec, FastText, and BERT for feature extraction. The experimental results on the MiniNewsGroup, 20NewsGroup Large dataset, and Reuters-21578 dataset show remarkable achievement in clustering outcomes in terms of purity and execution time. Results on the enormous data collection 20NewsGroup Large dataset show a better NMI (Normalized Mutual Information) score compared to the existing methods.
- 11 February 2023
- Published by Taylor & Francis in Cybernetics and Systems
- Vol. 56 (5) , 526-543
An Efficient Document Clustering Approach for Devising Semantic Clusters
The rise of superfluous information day by day has made the clustering of information into meaningful sets challenging. We propose an efficient approach for obtaining semantic clusters from a huge volume of documents. The preprocessing based on the lexical ontological information from WordNet helps in reducing the feature space and eliminating synonymy problems among the features. A considerable decrease in computational time is achieved by means of an enhanced k-means clustering algorithm. This algorithm computes the starting centroids using a sorting technique based on Red-Black Tree, thus ensuring efficiency and meaningful clusters. Memoization techniques are utilized in the subsequent stages, to avoid redundant computations. Results indicate that our method produces more meaningful clusters than those employing word embedding models like Word2Vec, FastText, and BERT for feature extraction. The experimental results on the MiniNewsGroup, 20NewsGroup Large dataset, and Reuters-21578 dataset show remarkable achievement in clustering outcomes in terms of purity and execution time. Results on the enormous data collection 20NewsGroup Large dataset show a better NMI (Normalized Mutual Information) score compared to the existing methods.
- 1 March 2019
- Published by Elsevier in Journal of Biomedical Informatics
- Vol. 91, 103112
Content based medical image retrieval using topic and location model
- 1 March 2019
- Published by Elsevier in Journal of Biomedical Informatics
- Vol. 91, 103112
Content based medical image retrieval using topic and location model
- 1 February 2018
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 72, 87-95
DEEPAligner: Deep encoding of pathways to align epigenetic signatures
- 1 February 2018
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 72, 87-95
DEEPAligner: Deep encoding of pathways to align epigenetic signatures
- Open Access
- 1 January 2018
- Published by Elsevier in Procedia Computer Science
- Vol. 132, 983-992
A novel clustering method to identify cell types from single cell transcriptional profiles
- 1 January 2018
- Published by Elsevier in Procedia Computer Science
- Vol. 132, 983-992
Open AccessA novel clustering method to identify cell types from single cell transcriptional profiles
- 1 December 2017
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 91, 213-221
An enhanced deterministic K-Means clustering algorithm for cancer subtype prediction from gene expression data
- 1 December 2017
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 91, 213-221
An enhanced deterministic K-Means clustering algorithm for cancer subtype prediction from gene expression data